trending Market Intelligence /marketintelligence/en/news-insights/trending/w3Q31mWzQTZY3tv_z_MEOQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Eli Lilly subsidiary secures exclusive rights to veterinary drug

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Eli Lilly subsidiary secures exclusive rights to veterinary drug

Elanco US Inc. secured the exclusive global rights to Jaguar Animal Health Inc.'s Canalevia for the potential treatment of acute and chemotherapy-induced diarrhea in dogs.

The Eli Lilly & Co. subsidiary will pay Jaguar Animal $1.5 million in up-front payment and another $61 million tied to the completion of certain milestones for the drug, which is currently under investigation.